Trial · NCT02100228
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants With Acute Stroke Event | Baseline up to 30 days post cardioversion (or up to 90 days after randomization, if cardioversion was not performed within that time frame) | Full analysis set included all randomized participants. | participants | NUMBER |
| PRIMARY | Number of Participants With Systemic Embolism Event | Baseline up to 30 days post cardioversion (or up to 90 days after randomization, if cardioversion was not performed within that time frame) | Full analysis set included all randomized participants. | participants | NUMBER |
| PRIMARY | Number of Participants With Major Bleeding Event | Baseline up to 30 days post cardioversion (or up to 90 days after randomization, if cardioversion was not performed within that time frame) | Safety data set included all treated participants (randomized participants who received at least one dose of study drug). | participants | NUMBER |
| PRIMARY | Number of Participants With Clinically Relevant Non-Major Bleeding Events | Baseline up to 30 days post cardioversion (or up to 90 days after randomization, if cardioversion was not performed within that time frame) | Safety data set included all treated participants (randomized participants who received at least one dose of study drug). | participants | NUMBER |
| PRIMARY | Number of Participants With All Cause Death | Baseline up to 30 days post cardioversion (or up to 90 days after randomization, if cardioversion was not performed within that time frame) | Full analysis set included all randomized participants. | participants | NUMBER |
| SECONDARY | Time to First Attempt of Cardioversion | Baseline up to Day of first attempt of cardioversion procedure (Visit 2, up to 130 days) | Full analysis set included all randomized participants. Here, N (number of participants analyzed) signifies participants who were evaluable for this specified outcome measure. | days | MEDIAN |
| SECONDARY | Number of Participants With Different Type of Cardioversion Events | Baseline up to Day of first attempt of cardioversion procedure (Visit 2, up to 130 days) | Full analysis set included all randomized participants. Here N signifies number of participants who were evaluable for this specified outcome measure. | participants | NUMBER |
| SECONDARY | Number of Cardioversion Attempt of Participants | Baseline up to Day of first attempt of cardioversion procedure (Visit 2, up to 130 days) | Full analysis set included all randomized participants. | participants | NUMBER |
| SECONDARY | Number of Participants With Their Rhythm Status | Baseline up to Day of first attempt of cardioversion procedure (Visit 2, up to 130 days) | Safety data set included all treated participants (randomized participants who received at least one dose of study drug). Here N signifies number of participants who were evaluable for this specified outcome measure. | participants | NUMBER |
| SECONDARY | Duration of Hospital Stay of Participants | Baseline up to Day of first attempt of cardioversion procedure (Visit 2, up to 130 days) | Full analysis set included all randomized participants. Here N signifies number of participants who were evaluable for this specified outcome measure. | hours | MEDIAN |
| SECONDARY | Number of Participants Who Used Image Guidance Approach | Baseline up to Day of first attempt of cardioversion procedure (Visit 2, up to 130 days) | Full analysis set included all randomized participants. | participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02100228/outcomes